The Prix Transparence 2019 honors a "Rundschau" contribution
«Rundschau» journalists Nina Blaser and Anielle Peterhans have been awarded the 2019 Prix Transparence. From among ten articles nominated by Öffentlichkeitsgesetz.ch, a jury of editors-in-chief selected the «Rundschau» article on the cancer drug «Perjeta» as last year’s best transparency story.
They fought tenaciously and brought the facts about the price negotiations on a cancer drug to the table. For this, the "Rundschau" journalists Nina Blaser and Anielle Peterhans are awarded the Prix Transparence 2019.
The files obtained by the two TV journalists prove an actual price poker between the Federal Office of Public Health (FOPH) and the Roche pharmaceutical group. Initially, Roche demanded 3950 Swiss francs per pack of medication, but the FOPH only wanted to approve 1850 Swiss francs. In the end, Roche pushed through the high price - and in return granted Swiss health insurers a discount of over 2,000 francs. A set-up, says an expert in the "Rundschau" report. Roche had wanted to negotiate a showcase price: "The higher the Swiss price, the more likely it is that you can demand a high price abroad."
Öffentlichkeitsgesetz.ch awards the Prix Transparence for the second time. The prize is awarded to media professionals who apply a publicity law in a targeted and effective manner.
Second place was awarded to the contribution of Sunday View-journalist Thomas Schlittler. Based on the law on public access, he has demanded a list of IV experts from the Federal Social Insurance Office (FSIO). Some commissioned doctors collected millions over the years. The journalist Lucien Fluri was awarded 3rd place. He used the Solothurn Information Act to obtain documents proving serious wage dumping among interns in day-care centers.
